| Boehringer signs renal disease research collaboration - PMLiVE |
|
|
PMLiVE Boehringer Ingelheim has signed a new research collaboration with Hydra Biosciences that will this time focus on renal diseases and disorders. It will work with the Cambridge, US-based firm, which has a focus on transient receptor potential (TRP |